The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type I
Abstract
OBJECTIVES: To explore whether aldosterone excess can induce adverse cardiovascular effects independently of effects on blood pressure (BP), we sought evidence of disturbed cardiovascular structure or function in normotensive individuals with primary aldosteronism. METHODS: Eight normotensive subjects with genetically proven familial hyperaldosteronism type I (FH-I) were compared with 24 age- and sex-matched normotensive controls in terms of BP, biochemical parameters, pulse wave velocity, and echocardiographic characteristics. RESULTS: Subjects with FH-I demonstrated higher serum aldosterone levels and aldosterone/renin ratios than controls, as expected. Despite having similar 24-h ambulatory BPs, subjects with FH-I demonstrated evidence of concentric remodeling with greater septal (mean +/- sd, 9.4 +/- 1.1 vs. 7.9 +/- 0.9 mm; P < 0.001), posterior wall (9.2 +/- 1.7 vs. 7.7 +/- 1.0 mm; P < 0.01), and relative wall (0.29 +/- 0.03 vs. 0.24 +/- 0.02; P < 0.001) thicknesses, and lower mitral early peak velocities (0.74 +/- 0.10 vs. 0.90 +/- 0.16 m/sec; P < 0.05), ratios of early to late peak diastolic transmitral flow velocity (1.56 +/- 0.24 vs. 2.06 +/- 0.41; P < 0.01), and myocardial early peak velocities (8.3 +/- 1.8 vs. 10.3 +/- 2.6 cm/sec; P < 0.05). There were no significant differences in pulse wave velocity or left ventricular ejection fraction, long axis strain rate, peak systolic strain, cyclic variation of integrated backscatter, or posterior wall calibrated integrated backscatter. CONCLUSIONS: Aldosterone excess is associated with increased left ventricular wall thicknesses and reduced diastolic function, even in the absence of hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,229
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
(2004) · PsycEXTRA Dataset · doi:10.1037/e442802008-001 · Cited by 2,875
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Zannad, F., Alla, F., Dousset, B., Perez, A., & Pitt, B. (2000) · Circulation · doi:10.1161/01.cir.102.22.2700 · Cited by 947
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Sutherland, D. J., Ruse, J. L., & Laidlaw, J. C. (1966) · PubMed · Cited by 542
Edvardsen, T., Gerber, B. L., Garot, J., Bluemke, D. A., Lima, J. A. C., & Smiseth, O. A. (2002) · Circulation · doi:10.1161/01.cir.0000019907.77526.75 · Cited by 523
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Koyama, J., Ray-Sequin, P. A., & Falk, R. H. (2003) · Circulation · doi:10.1161/01.cir.0000068313.67758.4f · Cited by 445
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
Echocardiographic detection of early diabetic myocardial disease
Fang, Z. Y., Yuda, S., Anderson, V., Short, L., Case, C., & Marwick, T. H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02869-3 · Cited by 369
Self-citationPrevalence of Primary Aldosteronism among Asian Hypertensive Patients in Singapore1
Loh, K.-C., Koay, E. S., Khaw, M.-C., Emmanuel, S. C., & Young, W. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6752 · Cited by 345
Changes in Left Ventricular Anatomy and Function in Hypertension and Primary Aldosteronism
Rossi, G. P., Sacchetto, A., Visentin, P., Canali, C., Graniero, G. R., Palatini, P., & Pessina, A. C. (1996) · Hypertension · doi:10.1161/01.hyp.27.5.1039 · Cited by 328
Rocha, R., Martin-Berger, C. L., Yang, P., Scherrer, R., Delyani, J., & McMahon, E. (2002) · Endocrinology · doi:10.1210/en.2002-220120 · Cited by 308
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90239-9 · Cited by 278
Mottram, P. M., Haluska, B., Leano, R., Cowley, D., Stowasser, M., & Marwick, T. H. (2004) · Circulation · doi:10.1161/01.cir.0000138680.89536.a9 · Cited by 278
Self-citationRemodeling of the Left Ventricle in Primary Aldosteronism Due to Conn’s Adenoma
Rossi, G. P., Sacchetto, A., Pavan, E., Palatini, P., Graniero, G. R., Canali, C., & Pessina, A. C. (1997) · Circulation · doi:10.1161/01.cir.95.6.1471 · Cited by 273
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P., Dow, E., Brennan, G., Jung, R., & MacDonald, T. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 269
Edvardsen, T., Skulstad, H., Aakhus, S., Urheim, S., & Ihlen, H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01160-8 · Cited by 262
Hyperparathyroidism and the Calcium Paradox of Aldosteronism
Chhokar, V. S., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., Myers, L. K., Xing, Z., Smith, R. A., Gerling, I. C., & Weber, K. T. (2005) · Circulation · doi:10.1161/01.cir.0000155621.10213.06 · Cited by 208
Rich, G. M., Ulick, S., Cook, S., Wang, J. Z., Lifton, R. P., & Dluhy, R. G. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-10-813 · Cited by 186
Skinner, S. L., Lumbers, E. R., & SYMONDS, E. M. (1969) · PubMed · Cited by 185
Wachtell, K., Smith, G., Gerdts, E., Dahlöf, B., Nieminen, M. S., Papademetriou, V., Bella, J. N., Ibsen, H., Rokkedal, J., & Devereux, R. B. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00773-0 · Cited by 161
Left ventricular hypertrophy. Relation of structure to diastolic function in hypertension.
Shapiro, L. M., & McKenna, W. J. (1984) · Heart · doi:10.1136/hrt.51.6.637 · Cited by 155
Jonsson, J. R., Klemm, S. A., Tunny, T. J., Stowasser, M., & Gordon, R. D. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1225 · Cited by 154
Self-citationBlacher, J., Amah, G., Girerd, X., Kheder, A., Mais, H. B., London, G. M., & Safar, M. E. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00301-4 · Cited by 153
CLINICAL AND PATHOLOGICAL DIVERSITY OF PRIMARY ALDOSTERONISM, INCLUDING A NEW FAMILIAL VARIETY
Gordon, R. D., Stowasser, M., Tunny, T. J., Klemm, S. A., Finn, W. L., & Krek, A. L. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01446.x · Cited by 146
Self-citationDuprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139
Primary aldosteronism: hypertension with a genetic basis
Gordon, R. D., Klemm, S. A., Tunny, T. J., & Stowasser, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)93225-c · Cited by 99
Self-citationPrimary Aldosteronism: Update on Diagnosis and Treatment
Young, W. F. (1997) · The Endocrinologist · doi:10.1097/00019616-199707040-00003 · Cited by 92
Mottram, P. M., Haluska, B., Yuda, S., Leano, R., & Marwick, T. H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.057 · Cited by 85
Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension
Douglas, P. S., & Tallant, B. (1991) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)80127-5 · Cited by 78
Kitamura, M., Shimizu, M., Ino, H., Okeie, K., Yamaguchi, M., Fujino, N., Mabuchi, H., & Nakanishi, I. (2001) · Clinical Cardiology · doi:10.1002/clc.4960240413 · Cited by 78
Non-invasive evaluation of arterial abnormalities in hypertensive patients
Asmar, R. G., Topouchian, J. A., Bénétos, A., Sayegh, F., Mourad, J., & Safar, M. E. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715022-00010 · Cited by 77
Myocardial Ultrasonic Backscatter in Hypertension
Kozàkovà, M., Buralli, S., Palombo, C., Bernini, G. P., Moretti, A., Favilla, S., Taddei, S., & Salvetti, A. (2003) · Hypertension · doi:10.1161/01.hyp.0000052542.68896.2b · Cited by 76
Yuda, S., Short, L., Leano, R., & Marwick, T. H. (2002) · Clinical Science · doi:10.1042/cs1030283 · Cited by 74
Self-citationStowasser, M., Bachmann, A. W., Huggard, P. R., Rossetti, T. R., & Gordon, R. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6651 · Cited by 64
Self-citationSato, A., Suzuki, Y., & Saruta, T. (1999) · Hypertension Research · doi:10.1291/hypres.22.17 · Cited by 61
Fibrosis of the Human Heart and Systemic Organs in Adrenal Adenoma
Campbell, S. E., Diaz‐Arias, A. A., & Weber, K. T. (1992) · Blood Pressure · doi:10.3109/08037059209077510 · Cited by 60
Schlaich, M. P., Schobel, H. P., Hilgers, K. F., & Schmieder, R. E. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00728-1 · Cited by 59
Plasma Renin Concentration, Activity, and Substrate in Hypertension Induced by Oral Contraceptives1
Beckerhoff, R., Luetscher, J. A., Wilkinson, R. W., et al. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-6-1067 · Cited by 52
Jamieson, A., Slutsker, L., Inglis, G. C., Fraser, R., White, P. C., & Connell, J. (1995) · Clinical Science · doi:10.1042/cs0880563 · Cited by 52
Primary aldosteronism: from genesis to genetics
Stowasser, M., & Gordon, R. D. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(03)00112-7 · Cited by 51
Self-citationStowasser, M., Huggard, P. R., Rossetti, T. R., Bachmann, A. W., & Gordon, R. D. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6159 · Cited by 49
Self-citationThe Aldosterone???Renin Ratio in Screening for Primary Aldosteronism
Stowasser, M., & Gordon, R. D. (2004) · The Endocrinologist · doi:10.1097/01.ten.0000139006.29471.9e · Cited by 41
Self-citationClinical, biochemical and genetic approaches to the detection of familial hyperaldosteronism type I
Bachmann, A. W., Jonsson, J. R., Tunny, T. J., Klemm, S. A., Gordon, R. D., & Stowasser, M. (1995) · Journal of Hypertension · doi:10.1097/00004872-199512010-00018 · Cited by 36
Self-citationStowasser, M., Gartside, M. G., & Gordon, R. D. (1997) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1997.tb00999.x · Cited by 36
Self-citation
Cited by
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Self-citationFunder, J. W., Carey, R. M., Fardella, C., Gomez-Sanchez, C. E., Mantero, F., Stowasser, M., Young, W. F., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0104 · Cited by 1,554
Self-citationHypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
Primary aldosteronism: renaissance of a syndrome
Young, W. F. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02775.x · Cited by 680
Douma, S., Petidis, K., Doumas, M., Papaefthimiou, P., Triantafyllou, A., Kartali, N., Papadopoulos, N., Vogiatzis, K., & Zamboulis, C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60834-x · Cited by 560
Metadata
- Authors
- Stowasser, M., Sharman, J., Leano, R., Gordon, R. D., Ward, G., Cowley, D., & Marwick, T. H.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-09
- Volume
- 90
- Issue
- 9
- Pages
- 5070-5076
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2156608900
- Cited by
- 271
- References
- 52
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.